Codexis Inc (CDXS)
3.61
-0.16
(-4.24%)
USD |
NASDAQ |
May 17, 16:00
3.61
0.00 (0.00%)
After-Hours: 20:00
Codexis Cash from Investing (Quarterly): -28.56M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -28.56M |
| December 31, 2023 | 1.104M |
| September 30, 2023 | -1.107M |
| June 30, 2023 | -1.571M |
| March 31, 2023 | -3.284M |
| December 31, 2022 | 0.033M |
| September 30, 2022 | -1.309M |
| June 30, 2022 | -2.22M |
| March 31, 2022 | -10.08M |
| December 31, 2021 | -5.48M |
| September 30, 2021 | -11.00M |
| June 30, 2021 | -2.412M |
| March 31, 2021 | -2.533M |
| December 31, 2020 | -2.488M |
| September 30, 2020 | -0.77M |
| June 30, 2020 | -1.729M |
| March 31, 2020 | -0.761M |
| December 31, 2019 | -0.414M |
| September 30, 2019 | -1.994M |
| June 30, 2019 | -0.812M |
| March 31, 2019 | -0.445M |
| December 31, 2018 | -0.693M |
| September 30, 2018 | -0.601M |
| June 30, 2018 | -1.456M |
| March 31, 2018 | -0.016M |
| Date | Value |
|---|---|
| December 31, 2017 | -0.245M |
| September 30, 2017 | -0.061M |
| June 30, 2017 | -0.441M |
| March 31, 2017 | -0.236M |
| December 31, 2016 | -0.098M |
| September 30, 2016 | -0.301M |
| June 30, 2016 | -0.209M |
| March 31, 2016 | -0.238M |
| December 31, 2015 | -0.899M |
| September 30, 2015 | -0.105M |
| June 30, 2015 | -0.206M |
| March 31, 2015 | -0.047M |
| December 31, 2014 | -0.033M |
| September 30, 2014 | 0.10M |
| June 30, 2014 | 0.974M |
| March 31, 2014 | 3.606M |
| December 31, 2013 | -0.441M |
| September 30, 2013 | 3.045M |
| June 30, 2013 | 8.216M |
| March 31, 2013 | 2.452M |
| December 31, 2012 | 10.80M |
| September 30, 2012 | 12.13M |
| June 30, 2012 | -6.219M |
| March 31, 2012 | -0.009M |
| December 31, 2011 | -1.557M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-28.56M
Minimum
Mar 2024
1.104M
Maximum
Dec 2023
-3.869M
Average
-1.862M
Median
Cash from Investing (Quarterly) Benchmarks
| Avidity Biosciences Inc | -32.75M |
| Taysha Gene Therapies Inc | -0.14M |
| Janux Therapeutics Inc | -113.74M |
| Tango Therapeutics Inc | -11.20M |
| 2seventy bio Inc | 21.83M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -7.789M |
| Cash from Financing (Quarterly) | 29.28M |
| Free Cash Flow | -54.22M |
| Free Cash Flow Per Share (Quarterly) | -0.1277 |
| Free Cash Flow to Equity (Quarterly) | -37.02M |
| Free Cash Flow to Firm (Quarterly) | -8.919M |
| Free Cash Flow Yield | -21.74% |